Topiramate exhibits anti-tumorigenic and metastatic effects in ovarian cancer cells.
Guangxu Xu(Jiangsu Province Hospital), Victoria Bae‐Jump(University of North Carolina at Chapel Hill), Yajie Yin(Parker Institute for Cancer Immunotherapy), Arthur-Quan Tran(University of North Carolina at Chapel Hill), Leslie H. Clark(University of North Carolina at Chapel Hill), Stephanie A. Sullivan(University of North Carolina at Chapel Hill), Jiandong Wang(Beijing Obstetrics and Gynecology Hospital), Weimin Kong(Capital Medical University), Rong Zhang(Army Medical University), Ziwei Fang(University of North Carolina at Chapel Hill), Wenchuan Sun(University of North Carolina at Chapel Hill), Chun Zhou(Guangdong Pharmaceutical University)
PubMed
January 1, 2018
Cited by 12
Related Papers
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
|Cancer Research|2005|467
CXCR4 Regulates Interneuron Migration in the Developing Neocortex
|Journal of Neuroscience|2003|455
Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition
|Molecular Cell|2019|169
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
|Cancer Medicine|2014|139
FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas
|Journal of Biological Chemistry|2013|134